Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

C225 shows absence of dose-limiting toxicity

May 31, 1996

ALRT-1057 exhibits high incidence of complete remission

May 31, 1996

U.S. Bioscience and Alza embark on marketing agreement for altretamine

May 31, 1996

Ligand reveals RXR-selective retinoid

May 31, 1996

MF-13 revealed as a selective tumor apoptosis-inducing agent

May 31, 1996

NSC-652287D shows important antitumor activity

May 31, 1996

Dainippon reveals compounds with antitumor activity

May 31, 1996

Spicamycin derivative revealed

May 31, 1996

Otsuka reveals matrix metalloproteinase inhibitors

May 31, 1996

Ciba-Geigy describes CGP-59326, a powerful antitumor agent

May 31, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 22, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 22, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...